How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy

How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy

Immune-checkpoint inhibitors (ICIs) represent a successful paradigm in the treatment of cancer. ICIs elicit an immune response directed against cancer cells, by targeting the so-called immune checkpoints, key regulators of the immune system that when stimulated can dampen the immune response to an i...

Full description

Bibliographic Details
Main Authors:	Paolo Spallarossa, Matteo Sarocchi, Giacomo Tini, Eleonora Arboscello, Matteo Toma, Pietro Ameri, Italo Porto
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-06-01
Series:	Frontiers in Pharmacology
Subjects:	checkpoint inhibition therapy myocarditis cardiotoxicity screening cardiovascular side effects troponin
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2020.00972/full

Similar Items

Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer
by: Giacomo Tini, et al.
Published: (2021-10-01)

Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01)

Cardiovascular complications of immune checkpoint inhibitors
by: A. A. Kulievа, et al.
Published: (2020-04-01)

Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis
by: Yunwei LIU, et al.
Published: (2021-09-01)

Clinical manifestation and management of immune checkpoint inhibitor‐associated cardiotoxicity
by: Xiaoxiao Guo, et al.
Published: (2020-02-01)

Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management
by: Muhammet Gürdoğan, et al.
Published: (2020-07-01)

Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: Case Series and Review of the Literature
by: Nikhil Agrawal, et al.
Published: (2019-03-01)

Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral Center
by: Jonas K. Kurzhals, et al.
Published: (2021-07-01)

Role of Cardiac Imaging in the Diagnosis of Immune Checkpoints Inhibitors Related Myocarditis
by: Stéphane Ederhy, et al.
Published: (2021-05-01)

Smoldering myocarditis following immune checkpoint blockade
by: Timothy G. Norwood, et al.
Published: (2017-11-01)

Cardiac Complications in Immune Checkpoint Inhibition Therapy
by: Kazuko Tajiri, et al.
Published: (2019-01-01)

Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
by: Kalyan R. Chitturi, DO, et al.
Published: (2019-12-01)

A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
by: Jessica Castrillon Lal, et al.
Published: (2021-05-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

Immune Checkpoint Inhibitors and Cardiac Toxicity in Patients Treated for Non-Small Lung Cancer: A Review
by: Grzegorz Sławiński, et al.
Published: (2020-09-01)

Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology
by: Dong-Yi Chen, et al.
Published: (2020-10-01)

An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline
by: Matteo Sarocchi, et al.
Published: (2018-10-01)

Cardiotoxicity and Mechanisms of Immune Checkpoint Inhibitors
by: DONG Shuang, et al.
Published: (2018-11-01)

Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
by: Yu-Wen Zhou, et al.
Published: (2019-11-01)

Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 1
by: Aleksey M. Chaulin
Published: (2021-09-01)

Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases
by: Emma Matzen, et al.
Published: (2021-08-01)

Cardiac diagnostic test results and outcomes in 44 dogs naturally infected with Trypanosoma cruzi
by: Derek J. Matthews, et al.
Published: (2021-07-01)

Clinical Diagnosis and Treatment Recommendations for Cardiac Adverse Reactions Related to Immune Checkpoint Inhibitor
by: Xiaoxiao GUO, et al.
Published: (2019-10-01)

Late-Onset Giant Cell Myocarditis Due to Enterovirus During Treatment With Immune Checkpoint Inhibitors
by: Mariana Mirabel, MD, PhD, et al.
Published: (2020-09-01)

Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta‐analysis
by: Lars Michel, et al.
Published: (2020-04-01)

Cardiac Troponins are Among Targets of Doxorubicin-Induced Cardiotoxicity in hiPCS-CMs
by: Michaela Adamcova, et al.
Published: (2019-05-01)

Peripheral Blood MicroRNAs as Potential Biomarkers of Myocardial Damage in Acute Viral Myocarditis
by: Maria Marketou, et al.
Published: (2021-03-01)

Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer
by: Lova Sun, MD, et al.
Published: (2019-12-01)

Myocardial and Pericardial Toxicity Associated With Immune Checkpoint Inhibitors in Cancer Patients
by: Johnny Chahine, MD, et al.
Published: (2020-02-01)

Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation
by: Roziakova Lubica, et al.
Published: (2012-02-01)

Gender differences in cardiotoxicities associated with immune checkpoint inhibitor therapy in cancer patients
by: Sheharyar Minhas, et al.
Published: (2020-01-01)

Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature
by: Feifei Wang, et al.
Published: (2021-07-01)

Cardiovascular Impacts of COVID-19 Pandemic: From Presentation to Management: Current and Future Perspectives
by: Zainab Atiyah Dakhil, et al.
Published: (2020-04-01)

Myocarditis in Coronavirus disease 2019: Not an equivalent to troponinitis
by: Saikrishna Reddy, et al.
Published: (2020-01-01)

Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy
by: Robin Jacob, MD, et al.
Published: (2020-11-01)

Cardiac troponin I as a cardiac biomarker has prognostic and predictive value for poor survival in Egyptian buffalo calves with foot-and-mouth disease
by: Mahmoud Aly, et al.
Published: (2020-05-01)

Cardiotoxicity of Anthracyclines
by: Daniela Cardinale, et al.
Published: (2020-03-01)

A systematic review of myasthenia gravis complicated with myocarditis
by: Wei Cheng, et al.
Published: (2021-08-01)

Immunotherapy-associated complete heart block in a patient with NSCLC: A case report and literature review
by: Alexander Vartanov, et al.
Published: (2021-01-01)

Immune Checkpoint Inhibitors and the Heart
by: Diana Larisa Mocan-Hognogi, et al.
Published: (2021-09-01)